Liver stem cells: From preface to advancements

Current Stem Cell Research and Therapy

Volumn 9, Issue 1, 2014, Pages 10-21

  Rehman, Kanwal ^a   Iqbal, Muhammad Javed ^b   Zahra, Nureen ^c   Akash, Muhammad Sajid Hamid ^a,d  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF GUJRAT   (Pakistan)

^c UNIVERSITY OF LAHORE   (Pakistan)

^d GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Bioartificial liver; Hepatocellular carcinoma; Hepatocytes; Oval cells; Stem progenitor cells

Indexed keywords

ANIMALS; CELL SEPARATION; DRUG EVALUATION, PRECLINICAL; HEPATOCYTES; HUMANS; LIVER; LIVER REGENERATION; STEM CELL NICHE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84898472809     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X113086660066     Document Type: Article

References (149)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292(5819): 154-6.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78(12): 7634-8.
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7.
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
5. Weissman I. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100(1): 157-68.
6. Robert P, Christine M. Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc Res 2003; 58(2): 324-35.
7. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 2002; 13(6): 389-96.
8. Smith A. A glossary for stem-cell biology. Nature 2006; 441: 1060.
9. Potten C, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties; lessons for and from the crypt. Development 1990; 110(4): 1101-20.
10. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. BioEssays 2002; 24(1): 91-8.
11. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before Liver Transplantation for HCC. Ann Surg Oncol 2008; 15(4): 993-1000.
12. Overturf K, Al-Dhalimy M, Ou C, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151(5): 1273-80.
13. Grompe M. The Role of Bone Marrow Stem Cells in Liver Regeneration. Semin Liver Dis 2003; 23(4): 363-72.
14. Itoh T, TanakaTanaka M, Miyajima A. Liver Stem Cells. In Regenerative Medicine 2011; (pp: 327-349). Springer Netherlands.
15. Tanaka M, Itoh T, Tanimizu N, Miyajima A. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J Biochem 2011; 149(3): 231-9.
16. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001; 294(5542): 559-63.
17. Antoniou A, Raynaud P, Cordi S, et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009; 136(7): 2325-33.
18. Onitsuka I, Tanaka M, Miyajima A. Characterization and functional analyses of hepatic mesothelial cells in mouse liver development. Gastroenterology 2010; 138(4): 1525-35.
19. Ijpenberg A, Pérez-Pomares JM, Guadix JA, et al. Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev Biol 2007; 312(1): 157-70.
20. Shafritz DA, Oertel M, Menthena A, Nierhoff D, Dabeva MD. Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology 2006; 43(2): S89-S98.
21. Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008; 1782(2): 61-74.
22. Dan YY, George CY. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 2008; 23(5): 687-98.
23. Michalopoulos G, DeFrances M. Liver regeneration. Science 1997; 276(5309): 60-6.
24. Rhim J, Sangren E, Degan J, Palmiter R, Brinster R. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263(5150): 1149-52.
25. Moore K, Lemischka I. Stem cells and their niches. Science 2006; 311(5769): 1880-85.
26. Mills JC, Gordon JI. The intestinal stem cell niche: There grows the neighborhood. Proc Natl Acad Sci USA 2001; 98(22): 12334-6.
27. Tumbar T, Guasch G, Greco V, et al. Defining the epithelial stem cell niche in skin. Science 2004; 303(5656): 359-63.
28. Conover JC, Notti RQ. The neural stem cell niche. Cell Tissue Res 2008; 331(1): 211-24.
29. Sugiyama T, Nagasawa T. Bone Marrow Niches for Hematopoietic Stem Cells and Immune Cells. Inflamm Allergy Drug Targets 2012; 11(3): 201-6.
30. Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS 2005; 113(11-12): 876-902.
31. Van Hul N, Abarca J, Sempoux C, Horsmans Y, Leclercq IA. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 2009; 49(5): 1625-35.
32. Alvaro D, Onori P, Met-aletal/et-alli VD, et al. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 2002; 36(2): 297-304.
33. Alvaro D, Alpini G, Onori P, et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology, 2002; 123(1): 336-44.
34. Alison MR, Islam S, Lim S. Stem cells in liver regeneration, brosis and cancer: the good, the bad and the ugly. J Pathol 2009; 217(2): 282-98.
35. Jakubowski A, Ambrose C, Parr M, et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 2005; 115(9): 2330-40.
36. Francis H, Glaser S, Demorrow S, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol 2008; 295(2): C499-C513.
37. Xiong A, Austin TW, Lagasse E, et al. Isolation of human fetal liver progenitors and their enhanced proliferation by threedimensional coculture with endothelial cells. Tissue Eng Part A 2008; 14(6): 995-1006.
38. Jindal R, Nahmias Y, Tilles AW, Berthiaume F, Yarmush ML. Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB Journal 2009; 23(7): 2288-98.
39. Krause P, Saghatolislam F, Koenig S, Unthan-Fechner K, Probst I. Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells. In vitro Cell Dev Biol Anim 2009; 45(5-6): 205-12.
40. Overturf K, al-Dhalimy M, Finegold M, Grome M. The repopulation potential of hepatocyte population differing in size and prior mitotic expansion. Am J Pathol 1999; 155(6): 2135-43.
41. Yuan R, Ogawa A, Ogawa E, Neufeld D, Zhu L, Shafritz D. p27Kip1 inactivation provides a proliferative advantage to transplanted hepatocytes in DPPIV/Rag2 double knockout mice after repeated host liver injury. Cell Transplant 2003; 12(8): 907-19.
42. Michalopoulos G, Barua L, Bowen W. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 2005; 41(3): 535-44.
43. Paku S, Schnur J, Nagy P, Thorgeirsson S. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001; 158(4): 1313-23.
44. Dabeva MD, Shafritz DA. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol 1993; 143(6): 1606-20.
45. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39(6): 1477-87.
46. Erker L, Grompe M. Signaling networks in hepatic oval cell activation. Stem cell Res 2008; 1(2): 90-102.
47. Knight B, Yeoh GC, Husk KL, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000; 192(12): 1809-18.
48. Akhurst B, Matthews V, Husk K, Smyth MJ, Abraham LJ, Yeoh GC. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 2005; 41(2): 327-35.
49. Duret C, Gerbal S, Ramos J, et al. Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells 2007; 25(7): 1779-90.
50. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120(1): 117-30.
51. Duncan A, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology 2009; 137(2): 466-81.
52. Theise N, Saxena R, Portmann B, et al. The canals of hering and hepatic stem cells in human. Hepatology 1999; 30(6): 1425-33.
53. Oertel M, Menthena A, Dabeva MD, Shafritz DA. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology 2006; 130(2): 507-20.
54. Mahieu-Caputo D, Allain JE, Branger J, et al. Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther 2004; 15(12): 1219-28.
55. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007; 56(5): 716-24.
56. Cai Y, Sheng C, Shu-Ying S, Zuo-Jun Z, Huan-Wei C. Passage of bone-marrow-derived liver stem cells in a proliferating culture system. World J Gastroenterol 2009; 13(13): 1630-5.
57. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001; 33(3): 738-50.
58. Fujio K, Evarts R, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in the adult rat. Lab Invest 1994; 70(4): 511-6.
59. Peterson B, Goff J, Greenberger J, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998; 27(2): 433-45.
60. Avital I, Inderbitzin D, Aoki T, et al. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun 2001; 288(1): 156-64.
61. Lee J, Thorgeirsson S. Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis 2005; 25(2): 125-32.
62. Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40(6): 1275-84.
63. Fujii H, Hirose T, Oe S, Yasuchika K, et al. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002; 36(5): 653-9.
64. Abe S, Lauby G, Boyer C, Rennard SI, Sharp JG. Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy 2003; 5(6): 523-33.
65. Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCL4-induced fibrosis in mice. Hepatology 2004; 40(6): 1304-11.
66. Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCL4-injured rats. J Hepatol 2006; 44(4): 742-8.
67. Terai S, Ishikawa T, Omori K, et al. Improved liver function in liver cirrhosis patients after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24(10): 2292-8.
68. Ksiazek K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuven Res 2009; 12(2): 105-16.
69. Kung JW, Forbes SJ. Stem cells and liver repair. Curr Opin Biotechnol 2009; 20(5): 568-74.
70. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5): 267-74.
71. Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 2007; 313(13): 2875-86.
72. Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007; 46(1): 219-28.
73. Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58(4): 570-81.
74. Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 2002; 20(3): 249-58.
75. De Ugarte DA, Alfonso Z, Zuk PA, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003; 89(2-3): 267-70.
76. Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004; 229(7): 623-31.
77. Reger RL, Tucker AH, Wolfe MR. Differentiation and characterization of human MSCs. Methods Mol Biol 2008; 449: 93-107.
78. Kuang D, Zhao X, Xiao G, et al. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol 2008; 103(3): 265-73.
79. Can A, Karahuseyinoglu S. Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25(11): 2886-95.
80. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoietic-supportive function and other potentials. Haematologica 2006; 91(8): 1017-26.
81. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 2007; 13(12): 1477-86.
82. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28(8): 875-84.
83. Bühring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W. Novel markers for the prospective isolation for human MSC. Ann N Y Acad Sci 2007; 1106: 262-71.
84. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25(2): 319-31.
85. Bakhshi T, Zabriskie RC, Bodie S, et al. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion 2008; 48(12): 2638-44.
86. Anzalone R, Iacono ML, Corrao S, et al. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 2010; 19(4): 423-38.
87. Lysy PA, Campard D, Smets F, et al. Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Prolif 2008; 41(1): 36-58.
88. Jameson E. Cellular Transplantation for Liver Diseases. Gastroenterol Res 2008; 1(1): 8-13.
89. Sancho-Bru P, Najimi M, Caruso M, et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 2009; 58(4): 594-603.
90. Braun KM, Degen JL, Sandgren EP. Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med 2000; 6(3): 320-6.
91. Wilson JM, Chowdhury NR, Grossman M, et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci USA 1990; 87(21): 8437-41.
92. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338(20): 1422-6.
93. Chowdhury JR, Chowdhury NR, Strom SC, Kaufman SS, Horslen S, Fox IJ. Human hepatocyte transplantation: gene therapy and more? Pediatrics 1998; 102(3): 647-8.
94. Nguyen TH, Birraux J, Wildhaber B, et al. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat. Transplantation 2006; 82(6): 794-803.
95. Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transplantation 2000; 6(1): 32-40.
96. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284(5417): 1168-70.
97. Fiegel HC, Lioznov MV, Cortes-Dericks L, et al. Liver-specific gene expression in cultured human hematopoietic stem cells. Stem Cells 2003; 21(1): 98-104.
98. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6(11): 1229-34.
99. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nature Cell Biol 2004; 6(6): 532-9.
100. Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58(8): 951-2.
101. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999; 19(1): 39-48.
102. Cho CH, Parashurama N, Park EY, et al. Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB Journal 2007; 22(3): 898-909.
103. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992; 24(6): 3052-3.
104. Lyra AC, Soares MB, da Silva LF, et al. Feasibility and safety of autologous bone mar-row mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13(7): 1067-73.
105. Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204(3): 1973-1987.
106. Weiss TS, Lichtenauer M, Kirchner S, et al. Hepatic progenitor cells from adult human livers for cell transplantation. Gut 2008; 57(8): 1129-38.
107. Dan YY. Clinical Uses of Liver Stem Cells. In Liver Stem Cells 2012; (pp. 11-23). Springer New York.
108. Streetz KL. Bio-arti cial liver devices-tentative, but promising progress. J Hepatol 2008; 48(2): 189-91.
109. Pearse MJ, Witort E, Mottram P, et al. Anti-gal antibody-mediated allograft rejection in alpha1,3-galactosyltrans-ferase gene knockout mice: a model of delayed xenograft rejection. Transplantation 1998; 66(6): 748-54.
110. Obermayer N, Busse B, Grünwald A, et al. Biochemical characterization of bioreactors for hybrid liver support: serum-free liver cell coculture of nonparenchymal and parenchymal cells. Transplant Proc 2001; 33(1-2): 1930-1.
111. Bartolo LD, Bader A. Flat membrane bioreactor for the replacement of liver functions. Ernst Schering Res Found Workshop 2002; (35): 89-104.
112. Fiegel HC, Kaufmann PM, Bruns H, et al. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2007; 12(1): 56-66
113. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24(6): 1446-51.
114. Sauer IM, Kardassis D, Zeillinger K, et al. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 2003; 10(5): 460-9.
115. Demetriou AA, Brown RS, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239(5): 660-7.
116. Poyck PP, van Wijk AC, van der Hoeven TV, et al. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioarti cial liver. J Hepatol 2008; 48(2): 266-75.
117. Kobayashi N. Life support of arti cial liver: development of a bioarti cial liver to treat liver failure. J Hepatobiliary Pancreat Surg 2009; 16(2): 113-7.
118. Schneider A, Attaran M, Meier PN, et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 2006; 82(2): 1115-6.
119. Choi SM, Kim Y, Shim JS, et al. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 2013; 57(6): 2458-68.
120. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23(3): 217-26.
121. Piscaglia AC, Campanale M, Gasbarrini A, Gasbarrini G. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int 2010; 2010: 259461.
122. Tanaka M, Okabe M, Suzuki K, et al. Mouse hepatoblasts at distinct developmental stages are characterized by expression of Ep-CAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev 2009; 126(8-9): 665-76.
123. Okabe M, Tsukahara Y, Tanaka M, et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 2009; 136(11): 1951-60.
124. Mao H, Yao-Kai C, Yu-Ming W, Lei Z,Guo-Dong L. Isolation, culture and identification of human fetal liver stem cells in vitro. World Chin J Digestol 2005; 15(4): 452-5.
125. Ma S, Chan KW, Hu L, et al. Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells. Gastroenterology 2007; 132(7): 2542-56.
126. Dan Y, Riehle K, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA 2006; 103(26): 9912-7.
127. Conigliaro1 A, Colletti M, Cicchini1 C, et al. Isolation and characterization of a murine resident liver stem cell. Cell Death Different 2008; 15(1): 123-33.
128. Knight B, Matthews VB, Olynyk JK, Yeoh GC. Jekyll and Hyde: evolving perspectives on the function and potential of the adult liver progenitor (oval) cell. Bioessays 2005; 27(11): 1192-202.
129. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2007; 414(6859): 105-11.
130. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132(7): 2557-76.
131. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003; 100(7): 3547-3549.
132. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8(10): 755-768.
133. Agarwal S, Holton KL, Lanza R. Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells. Stem Cells 2008; 26(5): 1117-27.
134. Kim N, Kim H, Jung I, Kim Y, Kim D, Han YM. Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res 2011; 41(2): 170-83.
135. Meng F, Glaser SS, Francis H, et al. Functional Analysis of microRNAs in HumanHepatocellular Cancer Stem Cells. J Cell Mol Med 2012; 16(1): 160-73.
136. Li R, Qian N, Tao K, You N, Wang X, Dou K. MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res 2010; 29: 169.
137. Cairo S, Wang Y, de Reyniès A, et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 2010; 107(47): 20471-6.
138. Xu C, Liu S, Fu H, et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 2010; 46(15): 2828-36.
139. Collino F, Deregibus MC, Bruno S, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PloS One 2010; 5(7): e11803.
140. Rogler CE, Levoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 2009; 50(2): 575-84.
141. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132(7): 2542-56.
142. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4(2): 143-153.
143. Villanueva A, Newell P, Chiang D, Friedman S and Llovet J. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007; 27(1): 55-76.
144. Marquardt J, Thorgeirsson S. Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis 2010; 30(1): 26-34.
145. Moon R, Kohn A, De Ferrari G, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 2004; 5(9): 691-701.
146. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006; 5(12): 997-1014.
147. Shachaf C, Kopelman A, Arvanitis C, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431(7012): 1112-7.
148. Bolos V, Grego J, Pompa J. Notch signaling in development and cancer. Endocr Rev 2007; 28(3): 339-63.
149. Tan J, Hytiroglou P, Wieczorek R, Park Y, Thung S, Arias B. Im munohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002; 22(5): 365-73.